Target host factors for treating viral infection

Details Target host factors for treating viral infection Target host factors for treating viral infection

A - Human Necessities

61

K

A61K 31/7088 (2006.01) A61K 31/713 (2006.01) A61P 31/12 (2006.01) A61P 31/16 (2006.01)

Patent

CA 2709132

A method of reducing virus-mediated cytotoxicity comprising contacting virus- infected cells with an effective amount of at least one inhibitor of ABI2, ARRDC3, BAD, BRCA1, C17orf85, C1orf71, C6orf162, CCNJL, CFL1, GON4L, HCG 1986447, HIST1H2AB, HPS4, LHX8, RPS25, RPL23, RPL32, LOC730139, LRRC39, MALT1, MX1, MERTK, MX2, NRG1, OR52A1, PLEKHH1, PTPN13, PTPRJ, RLN1, RNF19A, SH3BP4, SLC7A14, ST8SIA3, STX3, TMC6, TMTC4, TNFSF12-TNFSF13, TNFSF13, TTN, UBXN7, USP47, WNK2, YPEL2, ZNF251 and/or SCG2.

Affiliated with

Also associated with

Rating

Target host factors for treating viral infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Target host factors for treating viral infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Target host factors for treating viral infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1412998